These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 24985736)

  • 1. Branched-linear and agglomerate protein polymers as vaccine platforms.
    Wang L; Xia M; Huang P; Fang H; Cao D; Meng XJ; McNeal M; Jiang X; Tan M
    Biomaterials; 2014 Sep; 35(29):8427-38. PubMed ID: 24985736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A dual vaccine candidate against norovirus and hepatitis E virus.
    Wang L; Cao D; Wei C; Meng XJ; Jiang X; Tan M
    Vaccine; 2014 Jan; 32(4):445-52. PubMed ID: 24291540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polyvalent complexes for vaccine development.
    Wang L; Huang P; Fang H; Xia M; Zhong W; McNeal MM; Jiang X; Tan M
    Biomaterials; 2013 Jun; 34(18):4480-92. PubMed ID: 23498893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A trivalent vaccine candidate against hepatitis E virus, norovirus, and astrovirus.
    Xia M; Wei C; Wang L; Cao D; Meng XJ; Jiang X; Tan M
    Vaccine; 2016 Feb; 34(7):905-13. PubMed ID: 26778421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Norovirus P particle: a subviral nanoparticle for vaccine development against norovirus, rotavirus and influenza virus.
    Tan M; Jiang X
    Nanomedicine (Lond); 2012 Jun; 7(6):889-97. PubMed ID: 22734641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of three virus-derived nanoparticles as a vaccine against enteric pathogens; enterovirus, norovirus and rotavirus.
    Heinimäki S; Hankaniemi MM; Sioofy-Khojine AB; Laitinen OH; Hyöty H; Hytönen VP; Vesikari T; Blazevic V
    Vaccine; 2019 Dec; 37(51):7509-7518. PubMed ID: 31585726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous Immunization with Multivalent Norovirus VLPs Induces Better Protective Immune Responses to Norovirus Than Sequential Immunization.
    Malm M; Vesikari T; Blazevic V
    Viruses; 2019 Nov; 11(11):. PubMed ID: 31684058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and evaluation of two subunit vaccine candidates containing antigens of hepatitis E virus, rotavirus, and astrovirus.
    Xia M; Wei C; Wang L; Cao D; Meng XJ; Jiang X; Tan M
    Sci Rep; 2016 May; 6():25735. PubMed ID: 27194006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigenicity and immunogenicity of HA2 and M2e influenza virus antigens conjugated to norovirus-like, VP1 capsid-based particles by the SpyTag/SpyCatcher technology.
    Heinimäki S; Lampinen V; Tamminen K; Hankaniemi MM; Malm M; Hytönen VP; Blazevic V
    Virology; 2022 Jan; 566():89-97. PubMed ID: 34894525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trivalent combination vaccine induces broad heterologous immune responses to norovirus and rotavirus in mice.
    Tamminen K; Lappalainen S; Huhti L; Vesikari T; Blazevic V
    PLoS One; 2013; 8(7):e70409. PubMed ID: 23922988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioengineered Norovirus S
    Xia M; Huang P; Sun C; Han L; Vago FS; Li K; Zhong W; Jiang W; Klassen JS; Jiang X; Tan M
    ACS Nano; 2018 Nov; 12(11):10665-10682. PubMed ID: 30234973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A candidate dual vaccine against influenza and noroviruses.
    Xia M; Tan M; Wei C; Zhong W; Wang L; McNeal M; Jiang X
    Vaccine; 2011 Oct; 29(44):7670-7. PubMed ID: 21839795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Norovirus VLPs and rotavirus VP6 protein as combined vaccine for childhood gastroenteritis.
    Blazevic V; Lappalainen S; Nurminen K; Huhti L; Vesikari T
    Vaccine; 2011 Oct; 29(45):8126-33. PubMed ID: 21854823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Norovirus (NoV) specific protective immune responses induced by recombinant P dimer vaccine are enhanced by the mucosal adjuvant FlaB.
    Verma V; Tan W; Puth S; Cho KO; Lee SE; Rhee JH
    J Transl Med; 2016 May; 14(1):135. PubMed ID: 27184355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intranasal P particle vaccine provided partial cross-variant protection against human GII.4 norovirus diarrhea in gnotobiotic pigs.
    Kocher J; Bui T; Giri-Rachman E; Wen K; Li G; Yang X; Liu F; Tan M; Xia M; Zhong W; Jiang X; Yuan L
    J Virol; 2014 Sep; 88(17):9728-43. PubMed ID: 24920797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccine against norovirus.
    Tan M; Jiang X
    Hum Vaccin Immunother; 2014; 10(6):1449-56. PubMed ID: 24718366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A dual chicken IgY against rotavirus and norovirus.
    Dai YC; Zhang XF; Tan M; Huang P; Lei W; Fang H; Zhong W; Jiang X
    Antiviral Res; 2013 Mar; 97(3):293-300. PubMed ID: 23267830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural basis for the development of avian virus capsids that display influenza virus proteins and induce protective immunity.
    Pascual E; Mata CP; Gómez-Blanco J; Moreno N; Bárcena J; Blanco E; Rodríguez-Frandsen A; Nieto A; Carrascosa JL; Castón JR
    J Virol; 2015 Mar; 89(5):2563-74. PubMed ID: 25520499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune response and protective efficacy of the S particle presented rotavirus VP8* vaccine in mice.
    Xia M; Huang P; Jiang X; Tan M
    Vaccine; 2019 Jul; 37(30):4103-4110. PubMed ID: 31201052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity of candidate hepatitis E virus DNA vaccine expressing complete and truncated ORF2 in mice.
    Deshmukh TM; Lole KS; Tripathy AS; Arankalle VA
    Vaccine; 2007 May; 25(22):4350-60. PubMed ID: 17459540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.